Global Point-of-Care HbA1c Test Cartridges Market Growth 2026-2032

October 2026 | 192 pages | ID: G048E3993CF9EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Point-of-Care HbA1c Test Cartridges market size is predicted to grow from US$ 460 million in 2025 to US$ 797 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032.

Point-of-Care HbA1c Test Cartridges are single-use in vitro diagnostic consumables designed for quantitative glycated hemoglobin testing near the patient and used with dedicated or multi-assay point-of-care analyzers. These products typically integrate the reaction reagents, sample handling structure and optical or fluorescence detection interface into a sealed cartridge, cassette or reagent card, enabling HbA1c measurement from a small volume of capillary or venous whole blood within several minutes. Commercial products mainly employ boronate affinity, antibody agglutination and fluorescence immunoassay technologies, with representative sample requirements generally ranging from sub-microliter levels to approximately 5 ?L and assay times commonly within about 3–7 minutes. The market is centered on recurring disposable test consumables used in primary care clinics, diabetes specialty clinics, hospital outpatient departments, community health centers, pharmacies and long-term care facilities. Product demand is closely linked to installed point-of-care analyzer platforms, diabetes monitoring frequency, decentralized testing adoption and the ability of healthcare providers to obtain actionable HbA1c results during a single patient visit.

Key Findings

The market is characterized by recurring consumable demand linked to installed HbA1c point-of-care analyzer platforms

Boronate affinity and immunoassay-based cartridge systems represent the principal commercial technology routes

Market Trends

The Point-of-Care HbA1c Test Cartridges market is moving toward faster testing, smaller blood sample requirements, greater automation and broader integration with multi-assay point-of-care platforms. Product development is increasingly focused on simplified sample preparation, closed single-use reagent systems and reduced operator dependence, supporting wider deployment outside central laboratories. Dedicated HbA1c analyzers remain important in diabetes-focused settings, while multi-assay platforms are gaining relevance in primary care and decentralized clinical environments where providers seek to combine HbA1c with renal, lipid, inflammatory or other chronic disease markers on a single analyzer. Standardization and traceability remain central product requirements, with commercial systems increasingly emphasizing alignment with IFCC and NGSP reference frameworks. At the same time, the expansion of Asian manufacturers is increasing the availability of lower-cost cartridge systems, creating a broader price spectrum between premium international brands and competitively priced regional platforms.

Market Dynamics

Drivers

The principal market driver is the continued expansion of the global population requiring long-term diabetes management and periodic HbA1c monitoring. Point-of-care testing enables clinicians to obtain results during the same consultation, reducing dependence on separate laboratory visits and supporting more immediate treatment adjustment. Growth is also supported by wider deployment of HbA1c testing in primary care, community health centers and outpatient diabetes management. The recurring nature of cartridges creates a direct relationship between analyzer placement, testing frequency and consumable demand, while increasing adoption of decentralized chronic disease management further expands the addressable testing base.

Restraints

Market development is constrained by the continued dominance of centralized laboratory HbA1c testing in many healthcare systems, particularly where laboratory infrastructure is mature and reimbursement favors high-throughput testing. Point-of-care cartridges also carry higher per-test costs than some centralized laboratory reagent systems, which can limit adoption in price-sensitive public healthcare settings. Differences in analyzer compatibility and closed-platform consumable designs reduce interchangeability between manufacturers, while quality-control requirements, operator training and regulatory requirements for diagnostic use can increase the cost and complexity of implementation.

Opportunities

The strongest opportunities are concentrated in healthcare systems seeking to decentralize diabetes monitoring and improve patient follow-up. Primary care clinics, community-based chronic disease programs, pharmacies and regional medical centers represent important expansion areas because rapid HbA1c testing can shorten the diagnostic and treatment workflow. Emerging markets also provide substantial headroom as diabetes prevalence rises while laboratory access remains uneven. Multi-assay point-of-care platforms create an additional opportunity by allowing HbA1c cartridges to share installed instruments with other chronic disease tests, improving analyzer utilization and lowering the effective infrastructure cost per test.

Challenges

The industry faces continued pricing pressure as Chinese, Korean and other Asian manufacturers expand international registrations and supply competitively priced cartridges. Manufacturers must maintain analytical consistency across production batches while meeting strict standardization, calibration and quality-control requirements. Closed analyzer-cartridge ecosystems also increase dependence on installed instrument bases, making commercial success partly dependent on analyzer placement, distributor capability and local service infrastructure. In addition, differences in reimbursement, diagnostic regulations and point-of-care testing policies across countries can produce uneven adoption rates and complicate global market expansion.

Industry Chain Analysis

The upstream segment of the Point-of-Care HbA1c Test Cartridges industry includes antibodies, boronate affinity reagents, latex particles, fluorescent labels, buffers, membranes, microfluidic materials, optical components and injection-molded plastic cartridge structures. Manufacturing value is created through reagent formulation, biological material stabilization, precision dispensing, cartridge assembly, calibration, quality control and automated packaging. Because each cartridge must deliver reproducible quantitative results with small whole-blood samples, manufacturing consistency and calibration control are key barriers to entry. Automation capability becomes particularly important at higher volumes, as large POCT manufacturers can operate multi-product reagent and cartridge lines with annual output measured in tens or hundreds of millions of tests across their total diagnostic portfolios.

The midstream segment consists of integrated IVD manufacturers supplying proprietary HbA1c analyzers and recurring single-use consumables, as well as specialized OEM manufacturers producing cartridges for third-party brands. Downstream customers include primary care providers, diabetes clinics, hospital outpatient departments, community health centers, pharmacies and long-term care facilities. The value chain is therefore strongly influenced by installed analyzer bases: instruments create the testing platform, while recurring cartridges generate the majority of long-term consumable demand. Manufacturers with established analyzer placement, regulatory registrations, distribution networks and automated cartridge production generally have stronger recurring revenue visibility than suppliers relying primarily on standalone reagent sales.

Segment Insights

By product type, boronate affinity HbA1c cartridges form one of the most established technology groups because the method can provide rapid quantitative testing with small whole-blood samples and is widely used in dedicated HbA1c point-of-care analyzers. Antibody agglutination systems also maintain an important commercial position, particularly among established international analyzer platforms. Fluorescence immunoassay cartridges are more frequently associated with broader POCT platforms and are increasingly represented among Chinese and other Asian manufacturers. The competitive distinction between these categories is increasingly determined not only by analytical method but also by sample volume, assay time, ease of operation, calibration requirements and platform economics.

By analyzer platform, dedicated HbA1c systems remain important where testing volumes are concentrated around diabetes management, while multi-assay POCT platforms provide broader utilization opportunities in general practice and community medicine. The latter model can reduce dependence on a single test menu because one analyzer supports multiple diagnostic cartridges. As a result, platform breadth, installed-base expansion and consumable attachment rates are becoming increasingly important commercial variables in addition to the analytical performance of individual HbA1c cartridges.

Downstream Market Opportunities

Primary care represents a particularly important downstream opportunity because HbA1c testing can be completed during routine diabetes follow-up and linked directly to treatment decisions. Diabetes specialty clinics and hospital outpatient departments remain core high-frequency testing environments, while community health centers offer meaningful expansion potential in regions where centralized laboratory access is limited. Pharmacy-based testing and long-term care applications remain smaller but provide incremental opportunities for decentralized monitoring. The broader opportunity is shifting from simple substitution of laboratory testing toward integrated chronic disease management, where rapid HbA1c results improve patient workflow and allow healthcare providers to combine testing, consultation and medication adjustment within a single visit.

Regional Insights

North America and Europe represent mature high-value markets characterized by established diabetes management pathways, broad physician-office testing infrastructure and strong penetration of internationally recognized analyzer platforms. These regions generally support higher cartridge pricing, but expansion is moderated by well-developed central laboratory systems and mature installed bases. Japan also maintains a specialized HbA1c point-of-care manufacturing base, with domestic manufacturers serving clinics and small medical institutions through compact dedicated platforms.

Asia-Pacific is increasingly important on both the supply and demand sides. China and South Korea have developed dense clusters of POCT manufacturers with capabilities in fluorescence immunoassay, boronate affinity testing, cartridge automation and OEM manufacturing, while China Taiwan also hosts established cartridge and analyzer suppliers. India and Southeast Asia represent important demand expansion markets as diabetes management infrastructure develops and decentralized testing becomes more accessible. Regional competition is therefore increasingly differentiated between premium international systems with established clinical networks and cost-competitive Asian platforms seeking broader regulatory registration and distribution coverage.

Competitive Landscape Analysis

The competitive landscape combines large diversified diagnostic groups, established POCT specialists and a growing group of Asian cartridge manufacturers. Abbott and Siemens Healthineers represent globally established HbA1c point-of-care platforms with strong installed-base and clinical-channel advantages, while companies such as ACON, Sinocare, SD BIOSENSOR, HORIBA, Nova Biomedical, i-SENS, Wondfo, Getein and Orient Gene contribute significant manufacturing and commercialization capabilities across different regional markets. Specialized manufacturers including Boditech Med, OSANG healthcare, GC Medical Science, EKF Diagnostics, TaiDoc, Apex Biotechnology, Goldsite, BioHermes and other regional producers broaden the competitive field through dedicated technology platforms, OEM manufacturing and lower-cost product positioning. Competition is increasingly shaped by analyzer placement, recurring cartridge consumption, regulatory certification, manufacturing automation, assay standardization and distributor coverage rather than cartridge price alone. OEM relationships are also structurally important, as several internationally marketed HbA1c systems are manufactured by third-party diagnostic producers, making manufacturer-level competition more concentrated than brand-level market visibility may suggest.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “Point-of-Care HbA1c Test Cartridges Industry Forecast” looks at past sales and reviews total world Point-of-Care HbA1c Test Cartridges sales in 2025, providing a comprehensive analysis by region and market sector of projected Point-of-Care HbA1c Test Cartridges sales for 2026 through 2032. With Point-of-Care HbA1c Test Cartridges sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-Care HbA1c Test Cartridges industry.

This Insight Report provides a comprehensive analysis of the global Point-of-Care HbA1c Test Cartridges landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-Care HbA1c Test Cartridges portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Point-of-Care HbA1c Test Cartridges market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-Care HbA1c Test Cartridges and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-Care HbA1c Test Cartridges.

This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-Care HbA1c Test Cartridges market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

  • Boronate Affinity HbA1c Cartridges
  • Antibody Agglutination HbA1c Cartridges
  • Fluorescence Immunoassay HbA1c Cartridges
  • Other

Segmentation by Analyzer Platform Scope:

  • Dedicated HbA1c Platform Cartridges
  • Multi-Assay POCT Platform Cartridges
  • Other

Segmentation by Application:

  • Primary Care Clinics
  • Diabetes Specialty Clinics
  • Hospital Outpatient Departments
  • Community Health Centers
  • Pharmacies
  • Long-Term Care Facilities
  • Other

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Abbott Diagnostics Technologies AS
  • Siemens Healthcare Diagnostics Inc.
  • ACON Laboratories, Inc.
  • Changsha Sinocare Inc.
  • SD BIOSENSOR, Inc.
  • HORIBA, Ltd.
  • Nova Biomedical Corporation
  • i-SENS, Inc.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Getein Biotech, Inc.
  • Zhejiang Orient Gene Biotech Co., Ltd.
  • Zybio Inc.
  • Boditech Med Inc.
  • OSANG healthcare Co., Ltd.
  • GC Medical Science Corporation
  • EKF-diagnostic GmbH
  • TaiDoc Technology Corporation
  • Apex Biotechnology Corp.
  • Goldsite Diagnostics Inc.
  • Wuxi BioHermes Bio&Medical Technology Co., Ltd.
  • Xiamen Biotime Biotechnology Co., Ltd.
  • Labnovation Technologies, Inc.
  • AEHEALTH LIMITED
  • J. Mitra & Co. Pvt. Ltd.
  • Anbio Xiamen Biotechnology Co., Ltd.
  • Skyla Corporation
  • DxGen Corp.
  • SAKAE Corporation
  • EMPECS Medical Device Co., Ltd.
  • EUROLyser Diagnostica GmbH
  • TASCOM Co., Ltd.
  • CareforU Co., Ltd.
  • Dr. M?ller Ger?tebau GmbH
  • Nanjing Vazyme Medical Technology Co., Ltd.
  • Vitrosens Biyoteknoloji A.?.

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Point-of-Care HbA1c Test Cartridges market?
  • What factors are driving Point-of-Care HbA1c Test Cartridges market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Point-of-Care HbA1c Test Cartridges market opportunities vary by end market size?
  • How does Point-of-Care HbA1c Test Cartridges break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Point-of-Care HbA1c Test Cartridges Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Point-of-Care HbA1c Test Cartridges by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Point-of-Care HbA1c Test Cartridges by Country/Region, 2021, 2025 & 2032
2.2 Point-of-Care HbA1c Test Cartridges Segment by Type
  2.2.1 Boronate Affinity HbA1c Cartridges
  2.2.2 Antibody Agglutination HbA1c Cartridges
  2.2.3 Fluorescence Immunoassay HbA1c Cartridges
  2.2.4 Other
  2.2.5 Point-of-Care HbA1c Test Cartridges Sales by Type
    2.2.5.1 Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Type (2021-2026)
    2.2.5.2 Global Point-of-Care HbA1c Test Cartridges Revenue and Market Share by Type (2021-2026)
    2.2.5.3 Global Point-of-Care HbA1c Test Cartridges Sale Price by Type (2021-2026)
2.3 Point-of-Care HbA1c Test Cartridges Segment by Analyzer Platform Scope
  2.3.1 Dedicated HbA1c Platform Cartridges
  2.3.2 Multi-Assay POCT Platform Cartridges
  2.3.3 Other
  2.3.4 Point-of-Care HbA1c Test Cartridges Sales by Analyzer Platform Scope
    2.3.4.1 Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Analyzer Platform Scope (2021-2026)
    2.3.4.2 Global Point-of-Care HbA1c Test Cartridges Revenue and Market Share by Analyzer Platform Scope (2021-2026)
    2.3.4.3 Global Point-of-Care HbA1c Test Cartridges Sale Price by Analyzer Platform Scope (2021-2026)
2.4 Point-of-Care HbA1c Test Cartridges Segment by Application
  2.4.1 Primary Care Clinics
  2.4.2 Diabetes Specialty Clinics
  2.4.3 Hospital Outpatient Departments
  2.4.4 Community Health Centers
  2.4.5 Pharmacies
  2.4.6 Long-Term Care Facilities
  2.4.7 Other
  2.4.8 Point-of-Care HbA1c Test Cartridges Sales by Application
    2.4.8.1 Global Point-of-Care HbA1c Test Cartridges Sale Market Share by Application (2021-2026)
    2.4.8.2 Global Point-of-Care HbA1c Test Cartridges Revenue and Market Share by Application (2021-2026)
    2.4.8.3 Global Point-of-Care HbA1c Test Cartridges Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Point-of-Care HbA1c Test Cartridges Breakdown Data by Company
  3.1.1 Global Point-of-Care HbA1c Test Cartridges Annual Sales by Company (2021-2026)
  3.1.2 Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Company (2021-2026)
3.2 Global Point-of-Care HbA1c Test Cartridges Annual Revenue by Company (2021-2026)
  3.2.1 Global Point-of-Care HbA1c Test Cartridges Revenue by Company (2021-2026)
  3.2.2 Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Company (2021-2026)
3.3 Global Point-of-Care HbA1c Test Cartridges Sale Price by Company
3.4 Key Manufacturers Point-of-Care HbA1c Test Cartridges Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Point-of-Care HbA1c Test Cartridges Product Location Distribution
  3.4.2 Players Point-of-Care HbA1c Test Cartridges Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR POINT-OF-CARE HBA1C TEST CARTRIDGES BY GEOGRAPHIC REGION

4.1 World Historic Point-of-Care HbA1c Test Cartridges Market Size by Geographic Region (2021-2026)
  4.1.1 Global Point-of-Care HbA1c Test Cartridges Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Point-of-Care HbA1c Test Cartridges Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Point-of-Care HbA1c Test Cartridges Market Size by Country/Region (2021-2026)
  4.2.1 Global Point-of-Care HbA1c Test Cartridges Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Point-of-Care HbA1c Test Cartridges Annual Revenue by Country/Region (2021-2026)
4.3 Americas Point-of-Care HbA1c Test Cartridges Sales Growth
4.4 APAC Point-of-Care HbA1c Test Cartridges Sales Growth
4.5 Europe Point-of-Care HbA1c Test Cartridges Sales Growth
4.6 Middle East & Africa Point-of-Care HbA1c Test Cartridges Sales Growth

5 AMERICAS

5.1 Americas Point-of-Care HbA1c Test Cartridges Sales by Country
  5.1.1 Americas Point-of-Care HbA1c Test Cartridges Sales by Country (2021-2026)
  5.1.2 Americas Point-of-Care HbA1c Test Cartridges Revenue by Country (2021-2026)
5.2 Americas Point-of-Care HbA1c Test Cartridges Sales by Type (2021-2026)
5.3 Americas Point-of-Care HbA1c Test Cartridges Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Point-of-Care HbA1c Test Cartridges Sales by Region
  6.1.1 APAC Point-of-Care HbA1c Test Cartridges Sales by Region (2021-2026)
  6.1.2 APAC Point-of-Care HbA1c Test Cartridges Revenue by Region (2021-2026)
6.2 APAC Point-of-Care HbA1c Test Cartridges Sales by Type (2021-2026)
6.3 APAC Point-of-Care HbA1c Test Cartridges Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Point-of-Care HbA1c Test Cartridges by Country
  7.1.1 Europe Point-of-Care HbA1c Test Cartridges Sales by Country (2021-2026)
  7.1.2 Europe Point-of-Care HbA1c Test Cartridges Revenue by Country (2021-2026)
7.2 Europe Point-of-Care HbA1c Test Cartridges Sales by Type (2021-2026)
7.3 Europe Point-of-Care HbA1c Test Cartridges Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Point-of-Care HbA1c Test Cartridges by Country
  8.1.1 Middle East & Africa Point-of-Care HbA1c Test Cartridges Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Point-of-Care HbA1c Test Cartridges Revenue by Country (2021-2026)
8.2 Middle East & Africa Point-of-Care HbA1c Test Cartridges Sales by Type (2021-2026)
8.3 Middle East & Africa Point-of-Care HbA1c Test Cartridges Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-of-Care HbA1c Test Cartridges
10.3 Manufacturing Process Analysis of Point-of-Care HbA1c Test Cartridges
10.4 Industry Chain Structure of Point-of-Care HbA1c Test Cartridges

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Point-of-Care HbA1c Test Cartridges Distributors
11.3 Point-of-Care HbA1c Test Cartridges Customer

12 WORLD FORECAST REVIEW FOR POINT-OF-CARE HBA1C TEST CARTRIDGES BY GEOGRAPHIC REGION

12.1 Global Point-of-Care HbA1c Test Cartridges Market Size Forecast by Region
  12.1.1 Global Point-of-Care HbA1c Test Cartridges Forecast by Region (2027-2032)
  12.1.2 Global Point-of-Care HbA1c Test Cartridges Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Point-of-Care HbA1c Test Cartridges Forecast by Type (2027-2032)
12.7 Global Point-of-Care HbA1c Test Cartridges Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Abbott Diagnostics Technologies AS
  13.1.1 Abbott Diagnostics Technologies AS Company Information
  13.1.2 Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.1.3 Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Abbott Diagnostics Technologies AS Main Business Overview
  13.1.5 Abbott Diagnostics Technologies AS Latest Developments
13.2 Siemens Healthcare Diagnostics Inc.
  13.2.1 Siemens Healthcare Diagnostics Inc. Company Information
  13.2.2 Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.2.3 Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Siemens Healthcare Diagnostics Inc. Main Business Overview
  13.2.5 Siemens Healthcare Diagnostics Inc. Latest Developments
13.3 ACON Laboratories, Inc.
  13.3.1 ACON Laboratories, Inc. Company Information
  13.3.2 ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.3.3 ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 ACON Laboratories, Inc. Main Business Overview
  13.3.5 ACON Laboratories, Inc. Latest Developments
13.4 Changsha Sinocare Inc.
  13.4.1 Changsha Sinocare Inc. Company Information
  13.4.2 Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.4.3 Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Changsha Sinocare Inc. Main Business Overview
  13.4.5 Changsha Sinocare Inc. Latest Developments
13.5 SD BIOSENSOR, Inc.
  13.5.1 SD BIOSENSOR, Inc. Company Information
  13.5.2 SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.5.3 SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 SD BIOSENSOR, Inc. Main Business Overview
  13.5.5 SD BIOSENSOR, Inc. Latest Developments
13.6 HORIBA, Ltd.
  13.6.1 HORIBA, Ltd. Company Information
  13.6.2 HORIBA, Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.6.3 HORIBA, Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 HORIBA, Ltd. Main Business Overview
  13.6.5 HORIBA, Ltd. Latest Developments
13.7 Nova Biomedical Corporation
  13.7.1 Nova Biomedical Corporation Company Information
  13.7.2 Nova Biomedical Corporation Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.7.3 Nova Biomedical Corporation Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Nova Biomedical Corporation Main Business Overview
  13.7.5 Nova Biomedical Corporation Latest Developments
13.8 i-SENS, Inc.
  13.8.1 i-SENS, Inc. Company Information
  13.8.2 i-SENS, Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.8.3 i-SENS, Inc. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 i-SENS, Inc. Main Business Overview
  13.8.5 i-SENS, Inc. Latest Developments
13.9 Guangzhou Wondfo Biotech Co., Ltd.
  13.9.1 Guangzhou Wondfo Biotech Co., Ltd. Company Information
  13.9.2 Guangzhou Wondfo Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.9.3 Guangzhou Wondfo Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Guangzhou Wondfo Biotech Co., Ltd. Main Business Overview
  13.9.5 Guangzhou Wondfo Biotech Co., Ltd. Latest Developments
13.10 Getein Biotech, Inc.
  13.10.1 Getein Biotech, Inc. Company Information
  13.10.2 Getein Biotech, Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.10.3 Getein Biotech, Inc. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Getein Biotech, Inc. Main Business Overview
  13.10.5 Getein Biotech, Inc. Latest Developments
13.11 Zhejiang Orient Gene Biotech Co., Ltd.
  13.11.1 Zhejiang Orient Gene Biotech Co., Ltd. Company Information
  13.11.2 Zhejiang Orient Gene Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.11.3 Zhejiang Orient Gene Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Zhejiang Orient Gene Biotech Co., Ltd. Main Business Overview
  13.11.5 Zhejiang Orient Gene Biotech Co., Ltd. Latest Developments
13.12 Zybio Inc.
  13.12.1 Zybio Inc. Company Information
  13.12.2 Zybio Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.12.3 Zybio Inc. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Zybio Inc. Main Business Overview
  13.12.5 Zybio Inc. Latest Developments
13.13 Boditech Med Inc.
  13.13.1 Boditech Med Inc. Company Information
  13.13.2 Boditech Med Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.13.3 Boditech Med Inc. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Boditech Med Inc. Main Business Overview
  13.13.5 Boditech Med Inc. Latest Developments
13.14 OSANG healthcare Co., Ltd.
  13.14.1 OSANG healthcare Co., Ltd. Company Information
  13.14.2 OSANG healthcare Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.14.3 OSANG healthcare Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 OSANG healthcare Co., Ltd. Main Business Overview
  13.14.5 OSANG healthcare Co., Ltd. Latest Developments
13.15 GC Medical Science Corporation
  13.15.1 GC Medical Science Corporation Company Information
  13.15.2 GC Medical Science Corporation Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.15.3 GC Medical Science Corporation Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 GC Medical Science Corporation Main Business Overview
  13.15.5 GC Medical Science Corporation Latest Developments
13.16 EKF-diagnostic GmbH
  13.16.1 EKF-diagnostic GmbH Company Information
  13.16.2 EKF-diagnostic GmbH Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.16.3 EKF-diagnostic GmbH Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 EKF-diagnostic GmbH Main Business Overview
  13.16.5 EKF-diagnostic GmbH Latest Developments
13.17 TaiDoc Technology Corporation
  13.17.1 TaiDoc Technology Corporation Company Information
  13.17.2 TaiDoc Technology Corporation Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.17.3 TaiDoc Technology Corporation Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.17.4 TaiDoc Technology Corporation Main Business Overview
  13.17.5 TaiDoc Technology Corporation Latest Developments
13.18 Apex Biotechnology Corp.
  13.18.1 Apex Biotechnology Corp. Company Information
  13.18.2 Apex Biotechnology Corp. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.18.3 Apex Biotechnology Corp. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.18.4 Apex Biotechnology Corp. Main Business Overview
  13.18.5 Apex Biotechnology Corp. Latest Developments
13.19 Goldsite Diagnostics Inc.
  13.19.1 Goldsite Diagnostics Inc. Company Information
  13.19.2 Goldsite Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.19.3 Goldsite Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.19.4 Goldsite Diagnostics Inc. Main Business Overview
  13.19.5 Goldsite Diagnostics Inc. Latest Developments
13.20 Wuxi BioHermes Bio&Medical Technology Co., Ltd.
  13.20.1 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Company Information
  13.20.2 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.20.3 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.20.4 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Main Business Overview
  13.20.5 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Latest Developments
13.21 Xiamen Biotime Biotechnology Co., Ltd.
  13.21.1 Xiamen Biotime Biotechnology Co., Ltd. Company Information
  13.21.2 Xiamen Biotime Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.21.3 Xiamen Biotime Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.21.4 Xiamen Biotime Biotechnology Co., Ltd. Main Business Overview
  13.21.5 Xiamen Biotime Biotechnology Co., Ltd. Latest Developments
13.22 Labnovation Technologies, Inc.
  13.22.1 Labnovation Technologies, Inc. Company Information
  13.22.2 Labnovation Technologies, Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.22.3 Labnovation Technologies, Inc. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.22.4 Labnovation Technologies, Inc. Main Business Overview
  13.22.5 Labnovation Technologies, Inc. Latest Developments
13.23 AEHEALTH LIMITED
  13.23.1 AEHEALTH LIMITED Company Information
  13.23.2 AEHEALTH LIMITED Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.23.3 AEHEALTH LIMITED Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.23.4 AEHEALTH LIMITED Main Business Overview
  13.23.5 AEHEALTH LIMITED Latest Developments
13.24 J. Mitra & Co. Pvt. Ltd.
  13.24.1 J. Mitra & Co. Pvt. Ltd. Company Information
  13.24.2 J. Mitra & Co. Pvt. Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.24.3 J. Mitra & Co. Pvt. Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.24.4 J. Mitra & Co. Pvt. Ltd. Main Business Overview
  13.24.5 J. Mitra & Co. Pvt. Ltd. Latest Developments
13.25 Anbio Xiamen Biotechnology Co., Ltd.
  13.25.1 Anbio Xiamen Biotechnology Co., Ltd. Company Information
  13.25.2 Anbio Xiamen Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.25.3 Anbio Xiamen Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.25.4 Anbio Xiamen Biotechnology Co., Ltd. Main Business Overview
  13.25.5 Anbio Xiamen Biotechnology Co., Ltd. Latest Developments
13.26 Skyla Corporation
  13.26.1 Skyla Corporation Company Information
  13.26.2 Skyla Corporation Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.26.3 Skyla Corporation Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.26.4 Skyla Corporation Main Business Overview
  13.26.5 Skyla Corporation Latest Developments
13.27 DxGen Corp.
  13.27.1 DxGen Corp. Company Information
  13.27.2 DxGen Corp. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.27.3 DxGen Corp. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.27.4 DxGen Corp. Main Business Overview
  13.27.5 DxGen Corp. Latest Developments
13.28 SAKAE Corporation
  13.28.1 SAKAE Corporation Company Information
  13.28.2 SAKAE Corporation Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.28.3 SAKAE Corporation Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.28.4 SAKAE Corporation Main Business Overview
  13.28.5 SAKAE Corporation Latest Developments
13.29 EMPECS Medical Device Co., Ltd.
  13.29.1 EMPECS Medical Device Co., Ltd. Company Information
  13.29.2 EMPECS Medical Device Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.29.3 EMPECS Medical Device Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.29.4 EMPECS Medical Device Co., Ltd. Main Business Overview
  13.29.5 EMPECS Medical Device Co., Ltd. Latest Developments
13.30 EUROLyser Diagnostica GmbH
  13.30.1 EUROLyser Diagnostica GmbH Company Information
  13.30.2 EUROLyser Diagnostica GmbH Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.30.3 EUROLyser Diagnostica GmbH Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.30.4 EUROLyser Diagnostica GmbH Main Business Overview
  13.30.5 EUROLyser Diagnostica GmbH Latest Developments
13.31 TASCOM Co., Ltd.
  13.31.1 TASCOM Co., Ltd. Company Information
  13.31.2 TASCOM Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.31.3 TASCOM Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.31.4 TASCOM Co., Ltd. Main Business Overview
  13.31.5 TASCOM Co., Ltd. Latest Developments
13.32 CareforU Co., Ltd.
  13.32.1 CareforU Co., Ltd. Company Information
  13.32.2 CareforU Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.32.3 CareforU Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.32.4 CareforU Co., Ltd. Main Business Overview
  13.32.5 CareforU Co., Ltd. Latest Developments
13.33 Dr. M?ller Ger?tebau GmbH
  13.33.1 Dr. M?ller Ger?tebau GmbH Company Information
  13.33.2 Dr. M?ller Ger?tebau GmbH Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.33.3 Dr. M?ller Ger?tebau GmbH Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.33.4 Dr. M?ller Ger?tebau GmbH Main Business Overview
  13.33.5 Dr. M?ller Ger?tebau GmbH Latest Developments
13.34 Nanjing Vazyme Medical Technology Co., Ltd.
  13.34.1 Nanjing Vazyme Medical Technology Co., Ltd. Company Information
  13.34.2 Nanjing Vazyme Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.34.3 Nanjing Vazyme Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.34.4 Nanjing Vazyme Medical Technology Co., Ltd. Main Business Overview
  13.34.5 Nanjing Vazyme Medical Technology Co., Ltd. Latest Developments
13.35 Vitrosens Biyoteknoloji A.?.
  13.35.1 Vitrosens Biyoteknoloji A.?. Company Information
  13.35.2 Vitrosens Biyoteknoloji A.?. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
  13.35.3 Vitrosens Biyoteknoloji A.?. Point-of-Care HbA1c Test Cartridges Sales, Revenue, Price and Gross Margin (2021-2026)
  13.35.4 Vitrosens Biyoteknoloji A.?. Main Business Overview
  13.35.5 Vitrosens Biyoteknoloji A.?. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Point-of-Care HbA1c Test Cartridges Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Point-of-Care HbA1c Test Cartridges Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Boronate Affinity HbA1c Cartridges
Table 4. Major Players of Antibody Agglutination HbA1c Cartridges
Table 5. Major Players of Fluorescence Immunoassay HbA1c Cartridges
Table 6. Major Players of Other
Table 7. Global Point-of-Care HbA1c Test Cartridges Sales by Type (2021-2026) & (K Units)
Table 8. Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Type (2021-2026)
Table 9. Global Point-of-Care HbA1c Test Cartridges Revenue by Type (2021-2026) & ($ million)
Table 10. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Type (2021-2026)
Table 11. Global Point-of-Care HbA1c Test Cartridges Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Dedicated HbA1c Platform Cartridges
Table 13. Major Players of Multi-Assay POCT Platform Cartridges
Table 14. Major Players of Other
Table 15. Global Point-of-Care HbA1c Test Cartridges Sales by Analyzer Platform Scope (2021-2026) & (K Units)
Table 16. Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Analyzer Platform Scope (2021-2026)
Table 17. Global Point-of-Care HbA1c Test Cartridges Revenue by Analyzer Platform Scope (2021-2026) & ($ million)
Table 18. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Analyzer Platform Scope (2021-2026)
Table 19. Global Point-of-Care HbA1c Test Cartridges Sale Price by Analyzer Platform Scope (2021-2026) & (US$/Unit)
Table 20. Global Point-of-Care HbA1c Test Cartridges Sale by Application (2021-2026) & (K Units)
Table 21. Global Point-of-Care HbA1c Test Cartridges Sale Market Share by Application (2021-2026)
Table 22. Global Point-of-Care HbA1c Test Cartridges Revenue by Application (2021-2026) & ($ million)
Table 23. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Application (2021-2026)
Table 24. Global Point-of-Care HbA1c Test Cartridges Sale Price by Application (2021-2026) & (US$/Unit)
Table 25. Global Point-of-Care HbA1c Test Cartridges Sales by Company (2021-2026) & (K Units)
Table 26. Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Company (2021-2026)
Table 27. Global Point-of-Care HbA1c Test Cartridges Revenue by Company (2021-2026) & ($ millions)
Table 28. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Company (2021-2026)
Table 29. Global Point-of-Care HbA1c Test Cartridges Sale Price by Company (2021-2026) & (US$/Unit)
Table 30. Key Manufacturers Point-of-Care HbA1c Test Cartridges Producing Area Distribution and Sales Area
Table 31. Players Point-of-Care HbA1c Test Cartridges Products Offered
Table 32. Point-of-Care HbA1c Test Cartridges Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Market M&A Activity & Strategy
Table 35. Global Point-of-Care HbA1c Test Cartridges Sales by Geographic Region (2021-2026) & (K Units)
Table 36. Global Point-of-Care HbA1c Test Cartridges Sales Market Share Geographic Region (2021-2026)
Table 37. Global Point-of-Care HbA1c Test Cartridges Revenue by Geographic Region (2021-2026) & ($ millions)
Table 38. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Geographic Region (2021-2026)
Table 39. Global Point-of-Care HbA1c Test Cartridges Sales by Country/Region (2021-2026) & (K Units)
Table 40. Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Country/Region (2021-2026)
Table 41. Global Point-of-Care HbA1c Test Cartridges Revenue by Country/Region (2021-2026) & ($ millions)
Table 42. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Country/Region (2021-2026)
Table 43. Americas Point-of-Care HbA1c Test Cartridges Sales by Country (2021-2026) & (K Units)
Table 44. Americas Point-of-Care HbA1c Test Cartridges Sales Market Share by Country (2021-2026)
Table 45. Americas Point-of-Care HbA1c Test Cartridges Revenue by Country (2021-2026) & ($ millions)
Table 46. Americas Point-of-Care HbA1c Test Cartridges Sales by Type (2021-2026) & (K Units)
Table 47. Americas Point-of-Care HbA1c Test Cartridges Sales by Application (2021-2026) & (K Units)
Table 48. APAC Point-of-Care HbA1c Test Cartridges Sales by Region (2021-2026) & (K Units)
Table 49. APAC Point-of-Care HbA1c Test Cartridges Sales Market Share by Region (2021-2026)
Table 50. APAC Point-of-Care HbA1c Test Cartridges Revenue by Region (2021-2026) & ($ millions)
Table 51. APAC Point-of-Care HbA1c Test Cartridges Sales by Type (2021-2026) & (K Units)
Table 52. APAC Point-of-Care HbA1c Test Cartridges Sales by Application (2021-2026) & (K Units)
Table 53. Europe Point-of-Care HbA1c Test Cartridges Sales by Country (2021-2026) & (K Units)
Table 54. Europe Point-of-Care HbA1c Test Cartridges Revenue by Country (2021-2026) & ($ millions)
Table 55. Europe Point-of-Care HbA1c Test Cartridges Sales by Type (2021-2026) & (K Units)
Table 56. Europe Point-of-Care HbA1c Test Cartridges Sales by Application (2021-2026) & (K Units)
Table 57. Middle East & Africa Point-of-Care HbA1c Test Cartridges Sales by Country (2021-2026) & (K Units)
Table 58. Middle East & Africa Point-of-Care HbA1c Test Cartridges Revenue Market Share by Country (2021-2026)
Table 59. Middle East & Africa Point-of-Care HbA1c Test Cartridges Sales by Type (2021-2026) & (K Units)
Table 60. Middle East & Africa Point-of-Care HbA1c Test Cartridges Sales by Application (2021-2026) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Point-of-Care HbA1c Test Cartridges
Table 62. Key Market Challenges & Risks of Point-of-Care HbA1c Test Cartridges
Table 63. Key Industry Trends of Point-of-Care HbA1c Test Cartridges
Table 64. Point-of-Care HbA1c Test Cartridges Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Point-of-Care HbA1c Test Cartridges Distributors List
Table 67. Point-of-Care HbA1c Test Cartridges Customer List
Table 68. Global Point-of-Care HbA1c Test Cartridges Sales Forecast by Region (2027-2032) & (K Units)
Table 69. Global Point-of-Care HbA1c Test Cartridges Revenue Forecast by Region (2027-2032) & ($ millions)
Table 70. Americas Point-of-Care HbA1c Test Cartridges Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Americas Point-of-Care HbA1c Test Cartridges Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. APAC Point-of-Care HbA1c Test Cartridges Sales Forecast by Region (2027-2032) & (K Units)
Table 73. APAC Point-of-Care HbA1c Test Cartridges Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Europe Point-of-Care HbA1c Test Cartridges Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Europe Point-of-Care HbA1c Test Cartridges Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Middle East & Africa Point-of-Care HbA1c Test Cartridges Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Middle East & Africa Point-of-Care HbA1c Test Cartridges Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. Global Point-of-Care HbA1c Test Cartridges Sales Forecast by Type (2027-2032) & (K Units)
Table 79. Global Point-of-Care HbA1c Test Cartridges Revenue Forecast by Type (2027-2032) & ($ millions)
Table 80. Global Point-of-Care HbA1c Test Cartridges Sales Forecast by Application (2027-2032) & (K Units)
Table 81. Global Point-of-Care HbA1c Test Cartridges Revenue Forecast by Application (2027-2032) & ($ millions)
Table 82. Abbott Diagnostics Technologies AS Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 83. Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 84. Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Abbott Diagnostics Technologies AS Main Business
Table 86. Abbott Diagnostics Technologies AS Latest Developments
Table 87. Siemens Healthcare Diagnostics Inc. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 88. Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 89. Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Siemens Healthcare Diagnostics Inc. Main Business
Table 91. Siemens Healthcare Diagnostics Inc. Latest Developments
Table 92. ACON Laboratories, Inc. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 93. ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 94. ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. ACON Laboratories, Inc. Main Business
Table 96. ACON Laboratories, Inc. Latest Developments
Table 97. Changsha Sinocare Inc. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 98. Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 99. Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Changsha Sinocare Inc. Main Business
Table 101. Changsha Sinocare Inc. Latest Developments
Table 102. SD BIOSENSOR, Inc. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 103. SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 104. SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. SD BIOSENSOR, Inc. Main Business
Table 106. SD BIOSENSOR, Inc. Latest Developments
Table 107. HORIBA, Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 108. HORIBA, Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 109. HORIBA, Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. HORIBA, Ltd. Main Business
Table 111. HORIBA, Ltd. Latest Developments
Table 112. Nova Biomedical Corporation Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 113. Nova Biomedical Corporation Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 114. Nova Biomedical Corporation Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Nova Biomedical Corporation Main Business
Table 116. Nova Biomedical Corporation Latest Developments
Table 117. i-SENS, Inc. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 118. i-SENS, Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 119. i-SENS, Inc. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. i-SENS, Inc. Main Business
Table 121. i-SENS, Inc. Latest Developments
Table 122. Guangzhou Wondfo Biotech Co., Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 123. Guangzhou Wondfo Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 124. Guangzhou Wondfo Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Guangzhou Wondfo Biotech Co., Ltd. Main Business
Table 126. Guangzhou Wondfo Biotech Co., Ltd. Latest Developments
Table 127. Getein Biotech, Inc. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 128. Getein Biotech, Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 129. Getein Biotech, Inc. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Getein Biotech, Inc. Main Business
Table 131. Getein Biotech, Inc. Latest Developments
Table 132. Zhejiang Orient Gene Biotech Co., Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 133. Zhejiang Orient Gene Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 134. Zhejiang Orient Gene Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Zhejiang Orient Gene Biotech Co., Ltd. Main Business
Table 136. Zhejiang Orient Gene Biotech Co., Ltd. Latest Developments
Table 137. Zybio Inc. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 138. Zybio Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 139. Zybio Inc. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Zybio Inc. Main Business
Table 141. Zybio Inc. Latest Developments
Table 142. Boditech Med Inc. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 143. Boditech Med Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 144. Boditech Med Inc. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Boditech Med Inc. Main Business
Table 146. Boditech Med Inc. Latest Developments
Table 147. OSANG healthcare Co., Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 148. OSANG healthcare Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 149. OSANG healthcare Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. OSANG healthcare Co., Ltd. Main Business
Table 151. OSANG healthcare Co., Ltd. Latest Developments
Table 152. GC Medical Science Corporation Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 153. GC Medical Science Corporation Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 154. GC Medical Science Corporation Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. GC Medical Science Corporation Main Business
Table 156. GC Medical Science Corporation Latest Developments
Table 157. EKF-diagnostic GmbH Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 158. EKF-diagnostic GmbH Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 159. EKF-diagnostic GmbH Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. EKF-diagnostic GmbH Main Business
Table 161. EKF-diagnostic GmbH Latest Developments
Table 162. TaiDoc Technology Corporation Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 163. TaiDoc Technology Corporation Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 164. TaiDoc Technology Corporation Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. TaiDoc Technology Corporation Main Business
Table 166. TaiDoc Technology Corporation Latest Developments
Table 167. Apex Biotechnology Corp. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 168. Apex Biotechnology Corp. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 169. Apex Biotechnology Corp. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Apex Biotechnology Corp. Main Business
Table 171. Apex Biotechnology Corp. Latest Developments
Table 172. Goldsite Diagnostics Inc. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 173. Goldsite Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 174. Goldsite Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Goldsite Diagnostics Inc. Main Business
Table 176. Goldsite Diagnostics Inc. Latest Developments
Table 177. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 178. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 179. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Main Business
Table 181. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Latest Developments
Table 182. Xiamen Biotime Biotechnology Co., Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 183. Xiamen Biotime Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 184. Xiamen Biotime Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. Xiamen Biotime Biotechnology Co., Ltd. Main Business
Table 186. Xiamen Biotime Biotechnology Co., Ltd. Latest Developments
Table 187. Labnovation Technologies, Inc. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 188. Labnovation Technologies, Inc. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 189. Labnovation Technologies, Inc. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 190. Labnovation Technologies, Inc. Main Business
Table 191. Labnovation Technologies, Inc. Latest Developments
Table 192. AEHEALTH LIMITED Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 193. AEHEALTH LIMITED Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 194. AEHEALTH LIMITED Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 195. AEHEALTH LIMITED Main Business
Table 196. AEHEALTH LIMITED Latest Developments
Table 197. J. Mitra & Co. Pvt. Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 198. J. Mitra & Co. Pvt. Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 199. J. Mitra & Co. Pvt. Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 200. J. Mitra & Co. Pvt. Ltd. Main Business
Table 201. J. Mitra & Co. Pvt. Ltd. Latest Developments
Table 202. Anbio Xiamen Biotechnology Co., Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 203. Anbio Xiamen Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 204. Anbio Xiamen Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 205. Anbio Xiamen Biotechnology Co., Ltd. Main Business
Table 206. Anbio Xiamen Biotechnology Co., Ltd. Latest Developments
Table 207. Skyla Corporation Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 208. Skyla Corporation Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 209. Skyla Corporation Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 210. Skyla Corporation Main Business
Table 211. Skyla Corporation Latest Developments
Table 212. DxGen Corp. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 213. DxGen Corp. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 214. DxGen Corp. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 215. DxGen Corp. Main Business
Table 216. DxGen Corp. Latest Developments
Table 217. SAKAE Corporation Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 218. SAKAE Corporation Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 219. SAKAE Corporation Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 220. SAKAE Corporation Main Business
Table 221. SAKAE Corporation Latest Developments
Table 222. EMPECS Medical Device Co., Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 223. EMPECS Medical Device Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 224. EMPECS Medical Device Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 225. EMPECS Medical Device Co., Ltd. Main Business
Table 226. EMPECS Medical Device Co., Ltd. Latest Developments
Table 227. EUROLyser Diagnostica GmbH Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 228. EUROLyser Diagnostica GmbH Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 229. EUROLyser Diagnostica GmbH Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 230. EUROLyser Diagnostica GmbH Main Business
Table 231. EUROLyser Diagnostica GmbH Latest Developments
Table 232. TASCOM Co., Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 233. TASCOM Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 234. TASCOM Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 235. TASCOM Co., Ltd. Main Business
Table 236. TASCOM Co., Ltd. Latest Developments
Table 237. CareforU Co., Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 238. CareforU Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 239. CareforU Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 240. CareforU Co., Ltd. Main Business
Table 241. CareforU Co., Ltd. Latest Developments
Table 242. Dr. M?ller Ger?tebau GmbH Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 243. Dr. M?ller Ger?tebau GmbH Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 244. Dr. M?ller Ger?tebau GmbH Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 245. Dr. M?ller Ger?tebau GmbH Main Business
Table 246. Dr. M?ller Ger?tebau GmbH Latest Developments
Table 247. Nanjing Vazyme Medical Technology Co., Ltd. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 248. Nanjing Vazyme Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 249. Nanjing Vazyme Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 250. Nanjing Vazyme Medical Technology Co., Ltd. Main Business
Table 251. Nanjing Vazyme Medical Technology Co., Ltd. Latest Developments
Table 252. Vitrosens Biyoteknoloji A.?. Basic Information, Point-of-Care HbA1c Test Cartridges Manufacturing Base, Sales Area and Its Competitors
Table 253. Vitrosens Biyoteknoloji A.?. Point-of-Care HbA1c Test Cartridges Product Portfolios and Specifications
Table 254. Vitrosens Biyoteknoloji A.?. Point-of-Care HbA1c Test Cartridges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 255. Vitrosens Biyoteknoloji A.?. Main Business
Table 256. Vitrosens Biyoteknoloji A.?. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Point-of-Care HbA1c Test Cartridges
Figure 2. Point-of-Care HbA1c Test Cartridges Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Point-of-Care HbA1c Test Cartridges Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Point-of-Care HbA1c Test Cartridges Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Point-of-Care HbA1c Test Cartridges Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Point-of-Care HbA1c Test Cartridges Sales Market Share by Country/Region (2025)
Figure 10. Point-of-Care HbA1c Test Cartridges Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Boronate Affinity HbA1c Cartridges
Figure 12. Product Picture of Antibody Agglutination HbA1c Cartridges
Figure 13. Product Picture of Fluorescence Immunoassay HbA1c Cartridges
Figure 14. Product Picture of Other
Figure 15. Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Type in 2026
Figure 16. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Dedicated HbA1c Platform Cartridges
Figure 18. Product Picture of Multi-Assay POCT Platform Cartridges
Figure 19. Product Picture of Other
Figure 20. Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Analyzer Platform Scope in 2026
Figure 21. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Analyzer Platform Scope (2021-2026)
Figure 22. Point-of-Care HbA1c Test Cartridges Consumed in Primary Care Clinics
Figure 23. Global Point-of-Care HbA1c Test Cartridges Market: Primary Care Clinics (2021-2026) & (K Units)
Figure 24. Point-of-Care HbA1c Test Cartridges Consumed in Diabetes Specialty Clinics
Figure 25. Global Point-of-Care HbA1c Test Cartridges Market: Diabetes Specialty Clinics (2021-2026) & (K Units)
Figure 26. Point-of-Care HbA1c Test Cartridges Consumed in Hospital Outpatient Departments
Figure 27. Global Point-of-Care HbA1c Test Cartridges Market: Hospital Outpatient Departments (2021-2026) & (K Units)
Figure 28. Point-of-Care HbA1c Test Cartridges Consumed in Community Health Centers
Figure 29. Global Point-of-Care HbA1c Test Cartridges Market: Community Health Centers (2021-2026) & (K Units)
Figure 30. Point-of-Care HbA1c Test Cartridges Consumed in Pharmacies
Figure 31. Global Point-of-Care HbA1c Test Cartridges Market: Pharmacies (2021-2026) & (K Units)
Figure 32. Point-of-Care HbA1c Test Cartridges Consumed in Long-Term Care Facilities
Figure 33. Global Point-of-Care HbA1c Test Cartridges Market: Long-Term Care Facilities (2021-2026) & (K Units)
Figure 34. Point-of-Care HbA1c Test Cartridges Consumed in Other
Figure 35. Global Point-of-Care HbA1c Test Cartridges Market: Other (2021-2026) & (K Units)
Figure 36. Global Point-of-Care HbA1c Test Cartridges Sale Market Share by Application (2025)
Figure 37. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Application in 2025
Figure 38. Point-of-Care HbA1c Test Cartridges Sales by Company in 2025 (K Units)
Figure 39. Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Company in 2025
Figure 40. Point-of-Care HbA1c Test Cartridges Revenue by Company in 2025 ($ millions)
Figure 41. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Company in 2025
Figure 42. Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Point-of-Care HbA1c Test Cartridges Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Point-of-Care HbA1c Test Cartridges Sales 2021-2026 (K Units)
Figure 45. Americas Point-of-Care HbA1c Test Cartridges Revenue 2021-2026 ($ millions)
Figure 46. APAC Point-of-Care HbA1c Test Cartridges Sales 2021-2026 (K Units)
Figure 47. APAC Point-of-Care HbA1c Test Cartridges Revenue 2021-2026 ($ millions)
Figure 48. Europe Point-of-Care HbA1c Test Cartridges Sales 2021-2026 (K Units)
Figure 49. Europe Point-of-Care HbA1c Test Cartridges Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Point-of-Care HbA1c Test Cartridges Sales 2021-2026 (K Units)
Figure 51. Middle East & Africa Point-of-Care HbA1c Test Cartridges Revenue 2021-2026 ($ millions)
Figure 52. Americas Point-of-Care HbA1c Test Cartridges Sales Market Share by Country in 2025
Figure 53. Americas Point-of-Care HbA1c Test Cartridges Revenue Market Share by Country (2021-2026)
Figure 54. Americas Point-of-Care HbA1c Test Cartridges Sales Market Share by Type (2021-2026)
Figure 55. Americas Point-of-Care HbA1c Test Cartridges Sales Market Share by Application (2021-2026)
Figure 56. United States Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Point-of-Care HbA1c Test Cartridges Sales Market Share by Region in 2025
Figure 61. APAC Point-of-Care HbA1c Test Cartridges Revenue Market Share by Region (2021-2026)
Figure 62. APAC Point-of-Care HbA1c Test Cartridges Sales Market Share by Type (2021-2026)
Figure 63. APAC Point-of-Care HbA1c Test Cartridges Sales Market Share by Application (2021-2026)
Figure 64. China Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 68. India Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Point-of-Care HbA1c Test Cartridges Sales Market Share by Country in 2025
Figure 72. Europe Point-of-Care HbA1c Test Cartridges Revenue Market Share by Country (2021-2026)
Figure 73. Europe Point-of-Care HbA1c Test Cartridges Sales Market Share by Type (2021-2026)
Figure 74. Europe Point-of-Care HbA1c Test Cartridges Sales Market Share by Application (2021-2026)
Figure 75. Germany Point-of-Care HbA1c Test Cartridges Revenue Growth 2021-2026 ($ millions)